Compositions and methods for treating thyroid disease
AssigneeScript Essentials, LLC
InventorSuzy Cohen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a compound and method of using such compound, preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders, such as Hashimoto's thyroiditis. The unique combination of the composition is preferably administered orally via acid resistant or enteric-coated capsule, soft gel or tablet. The composition is preferably comprised of at least Catalase, Reduced Glutathione, Acetylated Glutathione, DPP-IV protease enzyme, Pepsin, Bromelain, Pancreatin, Vitamin D, and Selenium. The composition can further comprise a palliative agent, and can be provided in specific dosages or administered in forms besides those listed above.
Claims7
A method to treat a patient with Hashimoto's disease, comprising administering to said patient a composition comprising:
- 55 mcg of selenium;
- 250 mg of reduced glutathione;
- 50 mg of acetylated glutathione;
- 100 mg of dipeptidyl peptidase IV (DPP-IV) enzyme;
- 250 mg of bromelain;
- 250 mg of catalase;
- 20 mg of pepsin;
- 4000 IU of vitamin D3;
- and
- 200 mg of pancreatin enzyme.
Dependencies are inferred from the claim text.